The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 03, 2017
Filed:
Mar. 12, 2013
Applicant:
Abbvie Inc., North Chicago, IL (US);
Inventors:
John K Pratt, Kenosha, WI (US);
Dachun Liu, Vernon Hills, IL (US);
Chang H Park, Wadsworth, IL (US);
George S Sheppard, Wilmette, IL (US);
Lisa A Hasvold, Grayslake, IL (US);
Le Wang, Vernon Hills, IL (US);
Assignee:
AbbVie Inc., North Chicago, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4035 (2006.01); A61K 31/404 (2006.01); C07D 209/44 (2006.01); C07D 209/48 (2006.01); C07D 409/12 (2006.01); C07D 403/10 (2006.01); C07D 405/12 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); C07D 405/04 (2006.01); C07D 403/04 (2006.01); A61K 31/4184 (2006.01); C07D 405/10 (2006.01); C07D 401/12 (2006.01); A61K 31/4439 (2006.01); A61K 31/4709 (2006.01); C07D 403/12 (2006.01); A61K 31/416 (2006.01); C07D 417/12 (2006.01); A61K 31/427 (2006.01); C07D 401/10 (2006.01); C07D 409/10 (2006.01);
U.S. Cl.
CPC ...
C07D 409/12 (2013.01); A61K 31/404 (2013.01); A61K 31/4035 (2013.01); A61K 31/416 (2013.01); A61K 31/4184 (2013.01); A61K 31/427 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 209/44 (2013.01); C07D 209/48 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 403/10 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 409/10 (2013.01); C07D 417/12 (2013.01);
Abstract
The present invention provides for compounds of formula (I) wherein A, Y, J, R, R, and Rhave any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.